Tagomics Partners with Agilent Technologies to Revolutionize Multiomic Biomarker Discovery

Bio-Techne Partners with Leader Life Sciences to Expand in the GCC Region

Owkin and Proscia Partner to Revolutionize MSI Testing for Colorectal Cancer with AI-Powered Solutions

Telix Expands Theranostic Pipeline with FAP-Targeting Radiopharmaceuticals

Alamar Biosciences and The Michael J. Fox Foundation Partner to Advance Parkinson’s Disease Biomarker Discovery

Stilla Technologies Partners with Source BioScience to Advance Genomics in the UK and Ireland

Quell Therapeutics and AstraZeneca Advance CAR-Treg Therapy for Type 1 Diabetes

AbbVie’s ELAHERE® Approved in the EU for Platinum-Resistant Ovarian Cancer

AstraZeneca’s Tagrisso Recommended for Approval in EU for Unresectable EGFR-Mutated NSCLC

Foundation Medicine Receives FDA Approval for FoundationOne®Liquid CDx as a Companion Diagnostic for TEPMETKO® in NSCLC

Exact Sciences Partners with Carlos Ponce to Boost Colorectal Cancer Awareness in the Hispanic Community

Merck Receives Positive CHMP Opinion for KEYTRUDA® in Combination Therapy for First-Line Treatment of Non-Epithelioid Mesothelioma

Australia Launches Genomics Australia to Lead Advances in Genomic Medicine

Sidra Medicine Unveils Masterclasses Ahead of PMFG 2024 Summit

FDA Approves Revuforj® as First Menin Inhibitor for Acute Leukemia with KMT2A Translocation

Home
/
med-marvels
/
details

A New Hope: Odisha's First Successful CAR-T Cell Therapy Saves Young Life

NextEdge Admin

04 Oct 2024

2 min 18 sec

A 15-year-old girl named Trupti, suffering from blood cancer, received a new lease on life thanks to CAR-T cell therapy, successfully performed by a team at a prestigious hospital in Bhubaneswar. This marks the first successful CAR-T cell therapy for cancer treatment in Odisha and the fifth in India.

This groundbreaking therapy involves modifying a patient’s T-cells to target cancer cells more effectively. Trupti, who battled acute leukemia, became the first patient in eastern India to undergo this treatment. After undergoing chemotherapy, she received CAR-T cell therapy two days later. “My condition is normal now. There was a little fever, but I’m doing well. I’m grateful to all the doctors,” Trupti shared, filled with joy.

Dr. Priyanka Samal, Head of Clinical Hematology and Bone Marrow Transplant at IMS and SUM Hospital, highlighted that while CAR-T cell therapy is well-established in the West, it is still emerging in India. She reported that Trupti is thriving just a month after the procedure. The hospital's ability to provide this revolutionary treatment means patients no longer need to travel abroad and incur exorbitant costs.

Instead of spending crores, the therapy is available for approximately ₹30-35 lakh, a more affordable option in India. Trupti’s parents expressed their gratitude for their daughter's recovery, stating, “Every day is a blessing. We are just grateful to have our daughter back.” Trupti now dreams of becoming a doctor herself.